Gene · 1828
Papers3,287
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,287
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the neonatal Fc receptor in pemphigus: safety first. | Br J Dermatol | 2022 | 34961930 | PubTator, text mining | PubMed |
| Decreased FABP5 and DSG1 protein expression following PAX6 knockdown of differentiated human limbal epithelial cells. | Exp Eye Res | 2022 | 34954205 | PubTator, text mining | PubMed |
| Skin barrier defects in atopic dermatitis: From old idea to new opportunity. | Allergol Int | 2022 | 34916117 | PubTator, text mining | PubMed |
| Multiple cycles of rituximab therapy for pemphigus: A group of patients with difficult- to-treat disease or a consequence of late rituximab initiation? | Dermatol Ther | 2022 | 34910350 | PubTator, text mining | PubMed |
| Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor. | J Clin Invest | 2022 | 34905516 | Swiss-Prot, curated | PubMed |
| Antimicrobial peptide nisin induces spherical distribution of macropinocytosis-like cytokeratin 5 and cytokeratin 17 following immediate derangement of the cell membrane. | Anat Cell Biol | 2022 | 34903675 | PubTator, text mining | PubMed |
| Desmoglein-3 overexpression in oral squamous cell carcinoma is associated with metastasis formation and early recurrence: An immunohistochemical study. | J Craniomaxillofac Surg | 2022 | 34887169 | PubTator, text mining | PubMed |
| Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study. | J Dermatol | 2022 | 34866237 | PubTator, text mining | PubMed |
| Bullous and verrucous lichen sclerosus with autoantibodies against both desmoglein Dsg1 and Dsg3. | Int J Dermatol | 2022 | 34859893 | PubTator, text mining | PubMed |
| Messages from Mutant Desmosomes. | J Invest Dermatol | 2022 | 34799122 | PubTator, text mining | PubMed |
| Gene expression profiling of laminin α3-blocked keratinocytes reveals an immune-independent mechanism of blistering. | Exp Dermatol | 2022 | 34796550 | PubTator, text mining | PubMed |
| Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. | J Invest Dermatol | 2022 | 34756581 | PubTator, text mining | PubMed |
| Optimal application method of a moisturizer on the basis of skin physiological functions. | J Cosmet Dermatol | 2022 | 34743412 | PubTator, text mining | PubMed |
| RACK1 Prevents the Premature Differentiation of Epidermal Progenitor Cells by Inhibiting IRF6 Expression. | J Invest Dermatol | 2022 | 34742704 | PubTator, text mining | PubMed |
| Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris. | J Invest Dermatol | 2022 | 34710389 | PubTator, text mining | PubMed |
| Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti-desmoglein IgG autoantibodies in remission: a retrospective cohort study. | J Eur Acad Dermatol Venereol | 2022 | 34704306 | PubTator, text mining | PubMed |
| Mutations in SAM syndrome and palmoplantar keratoderma patients suggest genotype/phenotype correlations in DSG1 mutations. | J Eur Acad Dermatol Venereol | 2022 | 34657339 | Swiss-Prot, curated | PubMed |
| Utility of oral mucosa as a substrate for the serodiagnosis of pemphigus: A descriptive analysis. | Indian J Dermatol Venereol Leprol | 2022 | 34491669 | PubTator, text mining | PubMed |
| Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function. | Allergy | 2022 | 34458999 | PubTator, text mining | PubMed |
| Desmosomal Cadherins in Health and Disease. | Annu Rev Pathol | 2022 | 34425055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1828/papers?page=43